Latest Ubiquitin Research

Explore groundbreaking studies, reviews, and discoveries in ubiquitination pathways

Research Articles

Breaking the Shield: How SIK2 Inhibitor SIC-19 Makes Resistant Cancers Vulnerable to PARP Inhibitors

Discover how SIK2 inhibitor SIC-19 enhances PARP inhibitor sensitivity in triple-negative breast and pancreatic cancers through synthetic lethality approach.

Hudson Flores
Oct 25, 2025

Popular Articles